The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease
Open accessAbstract
BACKGROUND: The adverse effects of oral corticosteroids are widely recognised but there are few quantitative data on which to base advice to patients. In a two part cross sectional study we compared adverse effects in patients with lung disease taking oral corticosteroids and control subjects and related the adverse effects to corticosteroid dose in the patient group. METHODS: Data on oral corticosteroid use, lifestyle, fractures, and other possible adverse effects were collected by questionnaire and compared between a community based cohort of patients taking continuous or frequent intermittent oral corticosteroids for asthma, chronic obstructive pulmonary disease, or alveolitis and age and sex matched control subjects. Dose related effects were explored in the corticosteroid group using cumulative dose quartiles and multiple logistic regression. RESULTS: A total of 367 patients (> or = 50 years, 48% female) and 734 control subjects completed the questionnaire. The cumulative incidence of fractures since the time of diagnosis was 23% for patients taking oral corticosteroids and 15% in the control group (odds ratio (OR) 1.8; 95% confidence interval (CI) 1.3 to 2.6). Patients were more likely to have had a fracture of the vertebrae (OR 10; 95% CI 2.9 to 34), hip (OR 6; 95% CI 1.2 to 30), and ribs or sternum (OR 3.2, 95% CI 1.6 to 6.6) than control subjects. They also reported a significant increase in cataracts, use of antacids, muscle weakness, back pain, bruising, oral candidiasis, and having fewer teeth. The effects of oral corticosteroids were dose related: the odds ratio for patients in the highest compared with the lowest cumulative dose quartile (median prednisolone dose 61 g versus 5 g) ranged from 2 for all fractures to 9 for vertebral fractures and bruising. CONCLUSIONS: By quantifying the morbidity associated with the use of oral corticosteroids, this study should help to rationalise their long term use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A. D., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 674
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Self-citationPeel, N. F., Moore, D. J., Barrington, N. A., Bax, D. E., & Eastell, R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.10.801 · Cited by 379
Rheumatoid arthritis, corticosteroid therapy and hip fracture.
Cooper, C., Coupland, C., & Mitchell, M. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.1.49 · Cited by 352
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
Hubbard, R., Lewis, S., Richards, K., Johnston, I., & Britton, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90465-1 · Cited by 318
The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population
Dolan, P., & Torgerson, D. J. (1998) · Osteoporosis International · doi:10.1007/s001980050107 · Cited by 290
What Does the Odds Ratio Estimate in a Case-Control Study?
PEARCE, N. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.6.1189 · Cited by 266 · cited 1×
“Demographic, lifestyle, and all outcome measures were compared between the corticosteroid and matched control groups. The independent effect of corticosteroids on adverse effects was assessed using conditional logistic regression with appropriate interaction terms to assess any modifying effect of sex. Odds ratios wer…”
MethodVerstraeten, A., & Dequeker, J. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.10.852 · Cited by 214
Risk for periodontal disease in patients with longstanding rheumatoid arthritis
Käber, U. R., Michel, A., Bolten, W. W., Gleissner, C., Dehne, F., & Willershausen‐Zönnchen, B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401221 · Cited by 192
Cited by
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
“Two of these studies also evaluated the effects of daily dose and reported that cumulative dose was the stronger predictor of fracture [97,101].”
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease
Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-855oc · Cited by 1,256
“However, because patients with COPD tend to have higher prevalence of some comorbidities than the general elderly population (e.g., depression [17], osteoporosis [ 16 ], heart disease [18]), matching the populations for these comorbidities could arguably result in selection bias.”
BackgroundAfter asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Groenewegen, K. H., Schols, A. M. W. J., & Wouters, E. F. M. (2003) · Chest · doi:10.1378/chest.124.2.459 · Cited by 717
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
“Two smaller studies demonstrated that the cumulative (compared with daily) GC dose was the stronger predictor of fracture (8,9).”
BackgroundHanania, N. A., Alpan, O., Hamilos, D. L., Condemi, J. J., Reyes-Rivera, I., Zhu, J., Rosen, K. E., Eisner, M. D., Wong, D. A., & Busse, W. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00002 · Cited by 554
Epidemiology of Vertebral Fractures
Schousboe, J. T. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2015.08.004 · Cited by 451
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids
Poetker, D. M., & Reh, D. D. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.04.003 · Cited by 337
Sweeney, J., Patterson, C. C., Menzies-Gow, A., Niven, R. M., Mansur, A. H., Bucknall, C., Chaudhuri, R., Price, D., Brightling, C. E., & Heaney, L. G. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207630 · Cited by 331
Volmer, T., Effenberger, T., Trautner, C., & Buhl, R. (2018) · European Respiratory Journal · doi:10.1183/13993003.00703-2018 · Cited by 322
Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinion
Fardet, L., Flahault, A., Kettaneh, A., Tiev, K. P., Généreau, T., Tolédano, C., Lebbé, C., & Cabane, J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07950.x · Cited by 273
Manson, S. C., Brown, R. E., Cerulli, A., & Vidaurre, C. F. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.003 · Cited by 269
Hanania, N. A., King, M. J., Braman, S. S., Saltoun, C., Wise, R. A., Enright, P., Falsey, A. R., Mathur, S. K., Ramsdell, J. W., Rogers, L., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.048 · Cited by 263
The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
van Staa, T. P. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0019-1 · Cited by 260
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Sarnes, E., Crofford, L., Watson, M., Dennis, G., Kan, H., & Bass, D. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.009 · Cited by 258
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
Fardet, L., Kettaneh, A., Gérol, J., Tolédano, C., Tiev, K.-P., & Cabane, J. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.03.009 · Cited by 14
Metadata
- Authors
- Walsh, L. J.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2001-04-01
- Volume
- 56
- Issue
- 4
- Pages
- 279-284
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2138693512
- Cited by
- 253
- References
- 15
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.